Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

miR-15a and 16-1 are downregulated in CD4(+) T cells of multiple sclerosis relapsing patients.
Diosgenin promotes oligodendrocyte progenitor cell differentiation through estrogen receptor-mediated ERK1/2 activation to accelerate remyelination.
Multiple sclerosis: a primary care perspective.
Incidence of multiple sclerosis in Northern Lisbon, Portugal: 1998¿2007.
A practical review of the neuropathology and neuroimaging of multiple sclerosis.
On dihydroorotate dehydrogenases, their inhibitors and uses.
[Epidemiology of multiple sclerosis in the Primosky Krai and Far East regions.]
Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial.
The selective anti-IL17A monoclonal antibody secukinumab (AIN457) attenuates IL17A-induced levels of IL6 in human astrocytes.
Value and Efficacy of Transcranial Direct Current Stimulation in the Cognitive Rehabilitation: A Critical Review Since 2000.
[Budget impact analysis of the first-line treatment of relapsing remitting multiple sclerosis in Spain. Reply].
The antiepileptic drug valproic acid restores T cell homeostasis and ameliorates pathogenesis of experimental autoimmune encephalomyelitis.
Mesenchymal stem cells expressing vasoactive intestinal peptide ameliorate symptoms in a model of chronic multiple sclerosis.
An observational comparison of natalizumab vs. fingolimod using JCV serology to determine therapy.
Amiloride Hydrochlorothiazide as Treatment of Acute Inflammation of the Optic Nerve
Aquatic exercise effect on fatigue and quality of life of women with multiple sclerosis: a randomized controlled clinical trial.
Characterization of autologous mesenchymal stem cell-derived neural progenitors as a feasible source of stem cells for central nervous system applications in multiple sclerosis.
SMAD family proteins: the current knowledge on their expression and potential role in neoplastic diseases.
Physical activity and associated levels of disability and quality of life in people with multiple sclerosis: a large international survey.
Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor.
Towards establishing MS prevalence in Latin America and the Caribbean.
Immunohistochemical detection of sphingosine-1-phosphate and sphingosine kinase-1 in human tissue samples.
Inhibition of SLPI ameliorates disease activity in experimental autoimmune encephalomyelitis.
Sex ratio of multiple sclerosis in Canada: a longitudinal study.
Raltegravir (Isentress) pilot study in relapsing multiple sclerosis (INSPIRE)

Pages